Abstract
Benefits of primary chemotherapy in cases of breast invasive ductal carcinoma are widely accepted. However, the use of this therapy is controversial in cases of lobular invasive carcinoma: response rates are very poor–but not prognosis– and cases in which the breast can be conserved are very few. We present a rare case of bilateral synchronous breast cancer, a ductal carcinoma in the right breast and a lobular carcinoma in the left breast. It illustrates very clearly the controversy in which we currently are.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
